NEA Management Company’s Akari Therapeutics AKTX Stock Holding History

NEA Management Company’s Portfolio AKTX Stock Details AKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-565	Closed	-$89.3K	–	45
2023 Q3	$89.3K	Hold	565	–	–	0.01%	46
2023 Q2	$76.9K	Hold	565	–	–	0.01%	44
2023 Q1	$82.2K	Hold	565	–	–	0.01%	50
2022 Q4	$212K	Hold	565	–	–	0.01%	53
2022 Q3	$285K	Hold	565	–	–	0.01%	56
2022 Q2	$452K	Hold	565	–	–	0.02%	57
2022 Q1	$543K	Hold	565	–	–	0.02%	57
2021 Q4	$678K	Hold	565	–	–	0.01%	56
2021 Q3	$737K	Hold	565	–	–	0.01%	62
2021 Q2	$782K	Hold	565	–	–	0.01%	61
2021 Q1	$1.19M	Hold	565	–	–	0.03%	56
2020 Q4	$837K	Hold	565	–	–	0.02%	56
2020 Q3	$787K	Hold	565	–	–	0.03%	51
2020 Q2	$986K	Hold	565	–	–	0.04%	44
2020 Q1	$656K	Hold	565	–	–	0.03%	47
2019 Q4	$791K	Hold	565	–	–	0.04%	45
2019 Q3	$773K	Hold	565	–	–	0.06%	44
2019 Q2	$913K	Hold	565	–	–	0.06%	42
2019 Q1	$1.62M	Hold	565	–	–	0.08%	42
2018 Q4	$710K	Hold	565	–	–	0.03%	45
2018 Q3	$1.16M	Hold	565	–	–	0.05%	43
2018 Q2	$882K	Hold	565	–	–	0.04%	42
2018 Q1	$823K	Hold	565	–	–	0.04%	42
2017 Q4	$1.96M	Hold	565	–	–	0.08%	42
2017 Q3	$2.78M	Hold	565	–	–	0.1%	37
2017 Q2	$2.08M	Hold	565	–	–	0.08%	40
2017 Q1	$5M	Hold	565	–	–	0.17%	30
2016 Q4	$3.18M	Hold	565	–	–	0.13%	32
2016 Q3	$3.85M	Hold	565	–	–	0.17%	30
2016 Q2	$6.1M	Buy	+565	New	+$7.28M	0.32%	27
2016 Q1	–	Sell	-152	Closed	-$1.77M	–	38
2015 Q4	$1.77M	Buy	152 +118	+347%	+$1.75M	0.11%	32
2015 Q3	$645K	Buy	+34	New	+$402K	0.04%	35

Other funds holding AKTX

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

OFW

Omnia Family Wealth Aventura, Florida $373M AUM 25.3% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CPG

Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return

NEA Management Company's AKTX Position: Q4 2023 in Review

NEA Management Company sold out of Akari Therapeutics (AKTX) in Q4 2023, closing a stake of 565 shares — an estimated $89.3K sold.

NEA Management Company first reported a position in AKTX in Q3 2015 and held it in 32 quarters. The position peaked at $6.1M in Q2 2016. 6 funds tracked by Wall St. Rank hold AKTX as of Q4 2023.

NEA Management Company reported no remaining Akari Therapeutics position as of Q4 2023 after selling out during the quarter.
NEA Management Company sold 565 Akari Therapeutics shares in Q4 2023, an estimated $89.3K.
NEA Management Company first reported a position in Akari Therapeutics in Q3 2015 and held it in 32 quarters.
NEA Management Company's Akari Therapeutics position peaked at $6.1M in Q2 2016.
6 funds tracked by Wall St. Rank held Akari Therapeutics as of Q4 2023.

Based on NEA Management Company's 13F filing for Q4 2023, filed 14 Feb 2024.